These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11344823)
21. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? Dolff S; Abdulahad WH; Bijl M; Kallenberg CG Lupus; 2009 Jun; 18(7):575-80. PubMed ID: 19433456 [TBL] [Abstract][Full Text] [Related]
22. The role of immune ablation and stem cell transplantation in severe SLE. Pavletic SZ; Illei GG Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):839-58. PubMed ID: 16150406 [TBL] [Abstract][Full Text] [Related]
23. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Petri M; Jones RJ; Brodsky RA Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116 [TBL] [Abstract][Full Text] [Related]
24. Caring for the adolescent with systemic lupus erythematosus. Tucker LB Adolesc Med; 1998 Feb; 9(1):59-67, vi. PubMed ID: 10961252 [TBL] [Abstract][Full Text] [Related]
25. Clinical trials for lupus--are we there yet? Merrill JT Bull NYU Hosp Jt Dis; 2009; 67(3):267-70. PubMed ID: 19852748 [No Abstract] [Full Text] [Related]
26. Systemic lupus erythematosus: current state of diagnosis and treatment. Moldovan I Compr Ther; 2006; 32(3):158-62. PubMed ID: 17435268 [TBL] [Abstract][Full Text] [Related]
28. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus]. Amoura Z; Piette JC Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656 [TBL] [Abstract][Full Text] [Related]
29. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
30. [Transplantation of purified CD34+ stem cells from autologous peripheral blood for treatment of systemic lupus erythematosus]. Zeng K; Peng XB; Sun J; Xu D; Meng FY Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1052. PubMed ID: 12433652 [TBL] [Abstract][Full Text] [Related]
31. Clinical trial design in systemic lupus erythematosus. Dall'Era M; Wofsy D Curr Opin Rheumatol; 2006 Sep; 18(5):476-80. PubMed ID: 16896285 [TBL] [Abstract][Full Text] [Related]
34. [New concepts for the therapy of systemic lupus erythematosus]. Spertini F Rev Med Suisse; 2007 Jan; 3(94):98-102. PubMed ID: 17354532 [TBL] [Abstract][Full Text] [Related]
35. Systemic lupus erythematosus in children: current and emerging therapies. Macdermott EJ; Adams A; Lehman TJ Lupus; 2007; 16(8):677-83. PubMed ID: 17711907 [TBL] [Abstract][Full Text] [Related]
37. Stem cells in the aetiopathogenesis and therapy of rheumatic disease. Moore J; Tyndall A; Brooks P Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):711-26. PubMed ID: 11812017 [TBL] [Abstract][Full Text] [Related]
38. New therapies and preventive strategies to treat and minimize damage in lupus. Bouali H; Gilkeson G Curr Rheumatol Rep; 2005 Dec; 7(6):457-62. PubMed ID: 16303106 [TBL] [Abstract][Full Text] [Related]
39. New approaches for treatment of systemic lupus erythematosus. Bulman PM; Hunder G Ann Intern Med; 1998 Dec; 129(12):1095-6. PubMed ID: 9867785 [TBL] [Abstract][Full Text] [Related]